Morgan Stanley’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-5,305
| Closed | -$148K | – | 6931 |
|
|
2019
Q3 | $148K | Sell |
5,305
-320,693
| -98% | -$8.95M | ﹤0.01% | 5290 |
|
|
2019
Q2 | $4.6M | Buy |
325,998
+164,761
| +102% | +$2.32M | ﹤0.01% | 3000 |
|
|
2019
Q1 | $1.43M | Buy |
161,237
+140,781
| +688% | +$1.25M | ﹤0.01% | 3857 |
|
|
2018
Q4 | $155K | Sell |
20,456
-135,157
| -87% | -$1.02M | ﹤0.01% | 5386 |
|
|
2018
Q3 | $3.26M | Sell |
155,613
-159,787
| -51% | -$3.35M | ﹤0.01% | 3606 |
|
|
2018
Q2 | $9.44M | Sell |
315,400
-72,066
| -19% | -$2.16M | ﹤0.01% | 2444 |
|
|
2018
Q1 | $10.5M | Buy |
387,466
+175,174
| +83% | +$4.75M | ﹤0.01% | 2294 |
|
|
2017
Q4 | $6.12M | Buy |
212,292
+203,694
| +2,369% | +$5.87M | ﹤0.01% | 2880 |
|
|
2017
Q3 | $209K | Buy |
+8,598
| New | +$209K | ﹤0.01% | 5333 |
|